| Financial Year |
March 31 2023 |
| Monetary Funds |
541,485,122.28 |
| Held-for-trading Financial Assets |
14,180,528.86 |
| Notes Receivable |
-- |
| Accounts Receivable |
2,334,689.93 |
| Advances to Suppliers |
18,726,424.24 |
| Other Receivables |
6,133,346.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,331,356.51 |
| Total Current Assets |
590,191,467.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,490,308.63 |
| Investment Properties |
-- |
| Fixed Assetes |
16,769,696.88 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,303,671.20 |
| R&D expenses |
-- |
| Goodwill |
66,451,756.35 |
| Long-Term Deferred and Prepaid Expenses |
2,490,230.50 |
| Deferred Income Tax Assets |
10,467,838.09 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
132,869,323.72 |
| Total Assets |
723,060,791.61 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
3,384.13 |
| Notes Payable |
-- |
| Accounts Payable |
6,236,972.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,899,417.97 |
| Taxes Payable |
3,679,966.78 |
| Interest Payable |
-- |
| Dividend Payable |
1,908,243.03 |
| Other payables |
7,973,564.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,396,291.94 |
| Other Current Liabilities |
877,835.27 |
| Sub-Total of Current Liabilities |
256,137,407.31 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,494,186.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,838,874.58 |
| Total Liabilities |
261,976,281.89 |
| Paid-In Capital(Or Share Stock) |
101,019,233.00 |
| Capital Surplus |
326,336,522.60 |
| Surplus Reserve |
26,417,525.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,110,149.87 |
| Minority Stockholder's Interest |
9,996,074.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
451,088,434.74 |
| Owner's Equity（Stockholder's Equity） |
461,084,509.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
723,060,791.61 |
